July Deal Numbers Slide After a Spike in June
Minhua Chu · 09/01/2021
China’s biotech industry saw a dip in deal volume and value for innovative drugs in July after a rebound in the previous month. Chinese biotech companies made a total of 10 deals, with disclosed deal value amounting to over $1.5 billion.
READ MORE
June Numbers Spike with a Big In-Licensing Deal
Minhua Chu · 07/23/2021
China Licensing Deals Tracker: Jun 2021
READ MORE
China Licensing Deals Tracker: May 2021
Minhua Chu · 07/19/2021
LianBio Acquires Three Potential FIC Therapies for Cancer and IBD.
READ MORE
China Licensing Deals Tracker: Apr 2021
Minhua Chu · 07/19/2021
CANbridge Secures Two In-Licensing Deals for Rare Disease Therapies.
READ MORE
China Licensing Deals Tracker: Mar 2021
Minhua Chu · 07/19/2021
In-Licensing Deals Bring New Acid Reflux and Ophthalmic Treatments in to China
READ MORE
China Licensing Deals Tracker: Feb 2021
Minhua Chu · 07/19/2021
Junshi, Coherus Sign Deal Bringing New Cancer Drug to North America.
READ MORE
China Licensing Deals Tracker: Jan 2021
Minhua Chu · 07/19/2021
China's biopharmaceutical industry completed a dozen licensing deals in the first month of 2021, continuing its 2020 trend of cross-the-border hot licensing deals.
READ MORE
Copyright © 2016-2021 PharmaDJ .All Rights Reserved.   Suggestions and feedback: Support@PharmaDJ.com   Record/License No.:沪ICP备17054709号-1  
About PharmaDJ | Subscription | Contact Us | Copyright Statement